Hypercellular Bone Marrow

Preferred Label : Hypercellular Bone Marrow;

NCIt definition : An abnormal finding in a bone marrow aspirate or biopsy specimen indicating increased cellularity. It can result from hyperplasia of one or more hematopoietic cell lines or malignant neoplasms that affect the bone marrow.;

Détails

Origin ID

C35788;

UMLS CUI

C1334068;

Automatic exact mappings (from CISMeF team)
- Bone marrow hypercellularity [HPO term]
Peut être observé dans la(les) pathologie(s)
- Acute Basophilic Leukemia [NCIt concept]
- Acute Eosinophilic Leukemia [NCIt concept]
- Acute Erythroid Leukemia [NCIt concept]
- Acute Megakaryoblastic Leukemia [NCIt concept]
- Acute Megakaryoblastic Leukemia with CBFA2T3-GLIS2 [NCIt concept]
- Acute Monoblastic Leukemia [NCIt concept]
- Acute Monoblastic and Monocytic Leukemia [NCIt concept]
- Acute Monocytic Leukemia [NCIt concept]
- Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1 [NCIt concept]
- Acute Myeloid Leukemia Arising from Previous Chronic Myelomonocytic Leukemia [NCIt concept]
- Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome [NCIt concept]
- Acute Myeloid Leukemia Arising from Previous Myelodysplastic/Myeloproliferative Neoplasm [NCIt concept]
- Acute Myeloid Leukemia Arising from Previous Myeloproliferative Neoplasm [NCIt concept]
- Acute Myeloid Leukemia Post Cytotoxic Therapy [NCIt concept]
- Acute Myeloid Leukemia with BCR-ABL1 [NCIt concept]
- Acute Myeloid Leukemia with Biallelic CEBPA Mutation [NCIt concept]
- Acute Myeloid Leukemia with CEBPA Mutation [NCIt concept]
- Acute Myeloid Leukemia with FLT3/ITD Mutation [NCIt concept]
- Acute Myeloid Leukemia with FUS-ERG [NCIt concept]
- Acute Myeloid Leukemia with Germline CEBPA Mutation [NCIt concept]
- Acute Myeloid Leukemia with In-Frame bZIP CEBPA Mutation [NCIt concept]
- Acute Myeloid Leukemia with KAT6A-CREBBP [NCIt concept]
- Acute Myeloid Leukemia with KMT2A Rearrangement [NCIt concept]
- Acute Myeloid Leukemia with MECOM Rearrangement [NCIt concept]
- Acute Myeloid Leukemia with Maturation [NCIt concept]
- Acute Myeloid Leukemia with Minimal Differentiation [NCIt concept]
- Acute Myeloid Leukemia with Monoallelic CEBPA Mutation [NCIt concept]
- Acute Myeloid Leukemia with Multilineage Dysplasia [NCIt concept]
- Acute Myeloid Leukemia with NPM1 Mutation [NCIt concept]
- Acute Myeloid Leukemia with NPM1-MLF1 [NCIt concept]
- Acute Myeloid Leukemia with NUP98 Rearrangement [NCIt concept]
- Acute Myeloid Leukemia with Recurrent Genetic Abnormalities [NCIt concept]
- Acute Myeloid Leukemia with a Variant KMT2A Rearrangement [NCIt concept]
- Acute Myeloid Leukemia with a Variant MECOM Rearrangement [NCIt concept]
- Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 [NCIt concept]
- Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11 [NCIt concept]
- Acute Myeloid Leukemia with inv(3) (q21.3;q26.2); GATA2, MECOM [NCIt concept]
- Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM [NCIt concept]
- Acute Myeloid Leukemia with t(10;11)(p12.3;q23.3); MLLT10-KMT2A [NCIt concept]
- Acute Myeloid Leukemia with t(10;11)(q21.3;q23.3); TET1-KMT2A [NCIt concept]
- Acute Myeloid Leukemia with t(11;19)(q23.3;p13.1); KMT2A-ELL [NCIt concept]
- Acute Myeloid Leukemia with t(11;19)(q23.3;p13.3); KMT2A-MLLT1 [NCIt concept]
- Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 [NCIt concept]
- Acute Myeloid Leukemia with t(3;12)(q26.2;p13.2); ETV6-MECOM [NCIt concept]
- Acute Myeloid Leukemia with t(3;21)(q26.2;q22.1); MECOM-RUNX1 [NCIt concept]
- Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM [NCIt concept]
- Acute Myeloid Leukemia with t(3;8)(q26.2;q24); MYC, MECOM [NCIt concept]
- Acute Myeloid Leukemia with t(4;11)(q21.3;q23.3); AFF1-KMT2A [NCIt concept]
- Acute Myeloid Leukemia with t(6;11)(q27;q23.3); MLLT4-KMT2A [NCIt concept]
- Acute Myeloid Leukemia with t(6;9)(p22.3;q34.1); DEK-NUP214 [NCIt concept]
- Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6 [NCIt concept]
- Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1 [NCIt concept]
- Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A [NCIt concept]
- Acute Myeloid Leukemia without Maturation [NCIt concept]
- Acute Myeloid Leukemia, Myelodysplasia-Related [NCIt concept]
- Acute Myelomonocytic Leukemia [NCIt concept]
- Acute Myelomonocytic Leukemia with Abnormal Eosinophils [NCIt concept]
- Acute Myelomonocytic Leukemia without Abnormal Eosinophils [NCIt concept]
- Acute Promyelocytic Leukemia [NCIt concept]
- Acute Promyelocytic Leukemia with BCOR-RARA [NCIt concept]
- Acute Promyelocytic Leukemia with FIP1L1-RARA [NCIt concept]
- Acute Promyelocytic Leukemia with STAT3-RARA [NCIt concept]
- Acute Promyelocytic Leukemia with STAT5B-RARA [NCIt concept]
- Acute Promyelocytic Leukemia with TBL1XR1-RARA [NCIt concept]
- Acute Promyelocytic Leukemia with a Variant RARA Rearrangement [NCIt concept]
- Acute Promyelocytic Leukemia with t(11;17)(q13;q21); NUMA1-RARA [NCIt concept]
- Acute Promyelocytic Leukemia with t(11;17)(q23;q21); ZBTB16-RARA [NCIt concept]
- Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA [NCIt concept]
- Acute Promyelocytic Leukemia with t(1;17)(q42.3;q21.2); IRF2BP2-RARA [NCIt concept]
- Acute Promyelocytic Leukemia with t(5;17)(q35;q21); NPM1-RARA [NCIt concept]
- Adult Acute Basophilic Leukemia [NCIt concept]
- Adult Acute Eosinophilic Leukemia [NCIt concept]
- Adult Acute Erythroid Leukemia [NCIt concept]
- Adult Acute Megakaryoblastic Leukemia [NCIt concept]
- Adult Acute Monoblastic Leukemia [NCIt concept]
- Adult Acute Monoblastic and Monocytic Leukemia [NCIt concept]
- Adult Acute Monocytic Leukemia [NCIt concept]
- Adult Acute Myeloid Leukemia [NCIt concept]
- Adult Acute Myeloid Leukemia with Maturation [NCIt concept]
- Adult Acute Myeloid Leukemia with Minimal Differentiation [NCIt concept]
- Adult Acute Myeloid Leukemia with Recurrent Genetic Abnormalities [NCIt concept]
- Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11 [NCIt concept]
- Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 [NCIt concept]
- Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1 [NCIt concept]
- Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A [NCIt concept]
- Adult Acute Myeloid Leukemia without Maturation [NCIt concept]
- Adult Acute Myelomonocytic Leukemia [NCIt concept]
- Adult Acute Promyelocytic Leukemia [NCIt concept]
- Adult Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA [NCIt concept]
- Adult Erythroleukemia [NCIt concept]
- Adult Myelodysplastic Syndrome [NCIt concept]
- Adult Pure Erythroid Leukemia [NCIt concept]
- Aleukemic Monocytic Leukemia Cutis [NCIt concept]
- Alkylating Agent-Related Acute Myeloid Leukemia [NCIt concept]
- Alkylating Agent-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome [NCIt concept]
- Alkylating Agent-Related Myelodysplastic Syndrome [NCIt concept]
- Benzene-Related Acute Myeloid Leukemia [NCIt concept]
- Childhood Acute Basophilic Leukemia [NCIt concept]
- Childhood Acute Eosinophilic Leukemia [NCIt concept]
- Childhood Acute Erythroid Leukemia [NCIt concept]
- Childhood Acute Megakaryoblastic Leukemia [NCIt concept]
- Childhood Acute Megakaryoblastic Leukemia with NUP98-KDM5A [NCIt concept]
- Childhood Acute Monoblastic Leukemia [NCIt concept]
- Childhood Acute Monoblastic and Monocytic Leukemia [NCIt concept]
- Childhood Acute Monocytic Leukemia [NCIt concept]
- Childhood Acute Myeloid Leukemia [NCIt concept]
- Childhood Acute Myeloid Leukemia Not Otherwise Specified [NCIt concept]
- Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 5q [NCIt concept]
- Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 7 [NCIt concept]
- Childhood Acute Myeloid Leukemia with Maturation [NCIt concept]
- Childhood Acute Myeloid Leukemia with Minimal Differentiation [NCIt concept]
- Childhood Acute Myeloid Leukemia with NUP98 Rearrangement [NCIt concept]
- Childhood Acute Myeloid Leukemia with t(11;15)(p15;q35); NUP98-JARID1A [NCIt concept]
- Childhood Acute Myeloid Leukemia with t(5;11)(q35;p15); NUP98-NSD1 [NCIt concept]
- Childhood Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1 [NCIt concept]
- Childhood Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A [NCIt concept]
- Childhood Acute Myeloid Leukemia without Maturation [NCIt concept]
- Childhood Acute Myelomonocytic Leukemia [NCIt concept]
- Childhood Acute Promyelocytic Leukemia [NCIt concept]
- Childhood Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA [NCIt concept]
- Childhood Myelodysplastic Syndrome [NCIt concept]
- Childhood Myelodysplastic Syndrome with Excess Blasts [NCIt concept]
- Childhood Myelodysplastic Syndrome with Low Blasts [NCIt concept]
- Childhood Myelodysplastic Syndrome with Low Blasts, Hypocellular [NCIt concept]
- Childhood Myelodysplastic Syndrome with Low Blasts, Not Otherwise Specified [NCIt concept]
- Chronic Myelomonocytic Leukemia [NCIt concept]
- Chronic Myelomonocytic Leukemia with Eosinophilia [NCIt concept]
- Chronic Myelomonocytic Leukemia-0 [NCIt concept]
- Chronic Myelomonocytic Leukemia-1 [NCIt concept]
- Chronic Myelomonocytic Leukemia-2 [NCIt concept]
- Core Binding Factor Acute Myeloid Leukemia [NCIt concept]
- Cytogenetically Normal Acute Myeloid Leukemia Post Cytotoxic Therapy [NCIt concept]
- De Novo Myelodysplastic Syndrome [NCIt concept]
- Epipodophyllotoxin-Related Myelodysplastic Syndrome [NCIt concept]
- Erythroleukemia [NCIt concept]
- Essential Thrombocythemia [NCIt concept]
- Essential Thrombocythemia with CALR Mutation [NCIt concept]
- Essential Thrombocythemia with JAK2 Mutation [NCIt concept]
- Essential Thrombocythemia with MPL Mutation [NCIt concept]
- Essential Thrombocythemia with Recurrent Thrombosis [NCIt concept]
- Hereditary Myelodysplastic Syndrome [NCIt concept]
- Hypoplastic Myelodysplastic Syndrome [NCIt concept]
- Megakaryocytic Neoplasm [NCIt concept]
- Microgranular Acute Promyelocytic Leukemia [NCIt concept]
- Myelodysplastic Syndrome [NCIt concept]
- Myelodysplastic Syndrome Post Cytotoxic Therapy [NCIt concept]
- Myelodysplastic Syndrome with Biallelic TP53 Inactivation [NCIt concept]
- Myelodysplastic Syndrome with Biallelic TP53 Mutation [NCIt concept]
- Myelodysplastic Syndrome with Excess Blasts [NCIt concept]
- Myelodysplastic Syndrome with Excess Blasts and Fibrosis [NCIt concept]
- Myelodysplastic Syndrome with Excess Blasts-1 [NCIt concept]
- Myelodysplastic Syndrome with Genetic Abnormalities [NCIt concept]
- Myelodysplastic Syndrome with Low Blasts [NCIt concept]
- Myelodysplastic Syndrome with Monoallelic TP53 Mutation [NCIt concept]
- Myelodysplastic Syndrome with Mutated SF3B1 [NCIt concept]
- Myelodysplastic Syndrome with Mutated TP53 [NCIt concept]
- Myelodysplastic Syndrome with Ring Sideroblasts [NCIt concept]
- Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia [NCIt concept]
- Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia [NCIt concept]
- Myelodysplastic Syndrome with Somatic Mutation [NCIt concept]
- Myelodysplastic Syndrome with TP53 Inactivation [NCIt concept]
- Myelodysplastic Syndrome with del(5q) [NCIt concept]
- Myelodysplastic Syndrome, Not Otherwise Specified [NCIt concept]
- Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia [NCIt concept]
- Myelodysplastic Syndrome, Not Otherwise Specified with Single Lineage Dysplasia [NCIt concept]
- Myelodysplastic Syndrome, Unclassifiable [NCIt concept]
- Myelodysplastic Syndrome/Acute Myeloid Leukemia [NCIt concept]
- Myelodysplastic Syndrome/Acute Myeloid Leukemia with Mutated TP53 [NCIt concept]
- Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Cytogenetic Abnormalities [NCIt concept]
- Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations [NCIt concept]
- Myelodysplastic Syndrome/Acute Myeloid Leukemia, Not Otherwise Specified [NCIt concept]
- Myeloid Leukemia Associated with Down Syndrome [NCIt concept]
- Myeloproliferative Neoplasm, Not Otherwise Specified [NCIt concept]
- Overt Primary Myelofibrosis [NCIt concept]
- Pure Erythroid Leukemia [NCIt concept]
- Recurrent Acute Erythroid Leukemia [NCIt concept]
- Recurrent Acute Megakaryoblastic Leukemia [NCIt concept]
- Recurrent Acute Monoblastic and Monocytic Leukemia [NCIt concept]
- Recurrent Acute Monocytic Leukemia [NCIt concept]
- Recurrent Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome [NCIt concept]
- Recurrent Acute Myeloid Leukemia Post Cytotoxic Therapy [NCIt concept]
- Recurrent Acute Myeloid Leukemia with KMT2A Rearrangement [NCIt concept]
- Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia [NCIt concept]
- Recurrent Acute Myeloid Leukemia with Recurrent Genetic Abnormalities [NCIt concept]
- Recurrent Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A [NCIt concept]
- Recurrent Acute Myeloid Leukemia, Myelodysplasia-Related [NCIt concept]
- Recurrent Acute Myelomonocytic Leukemia [NCIt concept]
- Recurrent Acute Promyelocytic Leukemia [NCIt concept]
- Recurrent Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA [NCIt concept]
- Recurrent Adult Acute Myeloid Leukemia [NCIt concept]
- Recurrent Childhood Acute Myeloid Leukemia [NCIt concept]
- Recurrent Childhood Myelodysplastic Syndrome [NCIt concept]
- Recurrent Chronic Myelomonocytic Leukemia [NCIt concept]
- Recurrent Essential Thrombocythemia [NCIt concept]
- Recurrent Myelodysplastic Syndrome [NCIt concept]
- Recurrent Myelodysplastic Syndrome/Acute Myeloid Leukemia [NCIt concept]
- Recurrent Secondary Acute Myeloid Leukemia [NCIt concept]
- Refractory Acute Monoblastic and Monocytic Leukemia [NCIt concept]
- Refractory Acute Monocytic Leukemia [NCIt concept]
- Refractory Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome [NCIt concept]
- Refractory Acute Myeloid Leukemia Post Cytotoxic Therapy [NCIt concept]
- Refractory Acute Myelomonocytic Leukemia [NCIt concept]
- Refractory Anemia [NCIt concept]
- Refractory Childhood Myelodysplastic Syndrome [NCIt concept]
- Refractory Chronic Myelomonocytic Leukemia [NCIt concept]
- Refractory Cytopenia of Childhood [NCIt concept]
- Refractory Essential Thrombocythemia [NCIt concept]
- Refractory Myelodysplastic Syndrome [NCIt concept]
- Refractory Myelodysplastic Syndrome/Acute Myeloid Leukemia [NCIt concept]
- Refractory Neutropenia [NCIt concept]
- Refractory Secondary Acute Myeloid Leukemia [NCIt concept]
- Refractory Thrombocytopenia [NCIt concept]
- SAMD9-Associated Hereditary Myelodysplastic Syndrome [NCIt concept]
- SAMD9L-Associated Hereditary Myelodysplastic Syndrome [NCIt concept]
- Secondary Acute Myeloid Leukemia [NCIt concept]
- Secondary Acute Myeloid Leukemia in Acquired Aplastic Anemia [NCIt concept]
- Secondary Myelodysplastic Syndrome [NCIt concept]
- Secondary Myelodysplastic Syndrome in Acquired Aplastic Anemia [NCIt concept]
- Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia [NCIt concept]
- Typical Acute Promyelocytic Leukemia [NCIt concept]
Semantic type(s)
- Finding [UMLS semantic type]
is_finding_of_disease
- Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive [NCIt concept]
- Acute Panmyelosis with Myelofibrosis [NCIt concept]
- Atypical Chronic Myeloid Leukemia [NCIt concept]
- Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive [NCIt concept]
- Childhood Chronic Myeloid Leukemia, BCR-ABL1 Positive [NCIt concept]
- Chronic Eosinophilic Leukemia, Not Otherwise Specified [NCIt concept]
- Chronic Myeloid Leukemia, BCR-ABL1 Positive [NCIt concept]
- Chronic Myeloid Leukemia, Philadelphia Chromosome Negative, BCR-ABL1 Positive [NCIt concept]
- Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive [NCIt concept]
- Chronic Neutrophilic Leukemia [NCIt concept]
- Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive [NCIt concept]
- Chronic Phase Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive [NCIt concept]
- Juvenile Myelomonocytic Leukemia [NCIt concept]
- Juvenile Myelomonocytic Leukemia Associated with Neurofibromatosis [NCIt concept]
- Juvenile Myelomonocytic Leukemia Associated with Noonan Syndrome-Like Disorder [NCIt concept]
- Meningeal Chronic Myeloid Leukemia, BCR-ABL1 Positive [NCIt concept]
- Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified [NCIt concept]
- Polycythemia Vera, Polycythemic Phase [NCIt concept]
- Prefibrotic Primary Myelofibrosis [NCIt concept]
- Recurrent Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive [NCIt concept]
- Recurrent Acute Panmyelosis with Myelofibrosis [NCIt concept]
- Recurrent Atypical Chronic Myeloid Leukemia [NCIt concept]
- Recurrent Chronic Myeloid Leukemia, BCR-ABL1 Positive [NCIt concept]
- Recurrent Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive [NCIt concept]
- Recurrent Juvenile Myelomonocytic Leukemia [NCIt concept]
- Refractory Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive [NCIt concept]
- Refractory Atypical Chronic Myeloid Leukemia [NCIt concept]
- Refractory Chronic Myeloid Leukemia, BCR-ABL1 Positive [NCIt concept]
- Refractory Juvenile Myelomonocytic Leukemia [NCIt concept]
- Splenic Manifestation of Chronic Myeloid Leukemia, BCR-ABL1 Positive [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients